Tag Archives: news

NOVO NODISK GLOBAL PHARMACEUTICAL MEDICINE PROGRAMME

Application Deadline: 3 March, 2024

LOCATION: Denmark

Are you a medical doctor looking for a challenging career path in a pharmaceutical company? Would you like to work amongst highly qualified and ambitious teams in a global setting? Then this is your unique opportunity to apply for a position with three job rotations where you can use your medical and scientific knowledge to create better treatments and care for people around the world.

ELIGIBILITY:

In order to qualify for the PMP, you must hold a university degree as a medical doctor. You should have passed post-graduate internship and have 2-5 years of clinical experience.

Documented scientific experience is not a prerequisite, but it is an advantage. The programme offers an introduction to the pharmaceutical industry and the applicant should not have prior industry experience.

You must have practical and analytical skills and be capable of working independently, while at the same time being able to excel in a cross-functional, multi-disciplinary team. Moreover, you should be prepared to travel and work in an international arena.

We expect that you are results-oriented, are good at setting priorities, that you have a broad perspective and an open-mind, and are able to challenge the status quo. Lastly, we expect you to have excellent English skills and be proficient in IT.

Novo Nordisk is an international company and welcomes international applicants for the PMP programme.  English is the official company language. It is not a requirement to speak Danish, but there will be opportunities to learn the language. Novo Nordisk will provide relocation aid and support to new international employees and their family. Over the years candidates from China, Australia, Portugal, UK, Italy, Germany, Poland, Albania, Sweden and Denmark have been accepted into the programme. 

BENEFIT:

As a PMP, you will receive support and mentoring from the PMP manager, who is responsible for your development throughout your time on the programme. You will also have a manager in each host department, who is responsible for your development in each rotation. 

The programme aims to educate you within applied clinical drug development, the workings of the pharmaceutical industry and to prepare you for a career within the company. This is primarily achieved through assuming responsibilities in your host department, and through a generous training programme.

On successful completion of the programme, together with the PMP manager you will identify a suitable permanent position, within one of the programme’s three sponsor areas, tailored to your interests and company needs.

APPLY

THE SYSTEMSPECS CHILDREN’S DAY ESSAY COMPETITION 

Application Deadline: 20 April, 2024

LOCATION: Nigeria

At SystemSpecs, we believe it is possible to have a positive and safe experience online. However, we also recognize as a child, you need to be aware of the dangers of online technology.  And that’s why you are invited to share your thoughts on the 2024 topic: Protecting the Nigerian child from the dangers of online technology” and why it is important! Your perspective matters. We look forward to your submission. 

ELIGIBILITY:

Primary and secondary children schooling in Nigeria ages 9 years and not older than 16 years. 

The Junior category (ages 9 to 12) submits a maximum of 1,000 words, while the Senior category (ages 13 to 16) submits a maximum of 1,500 words.

Your essay must be in English. 

You are only allowed to submit one entry per participant. 

Your submission must be your original thoughts; plagiarism will not be tolerated! 

An accredited school official or parent or legal guardian must endorse your entry. 

You are allowed to re-submit only ONCE. To re-submit, please send an email of appeal to participate@systemspecs.com.ng stating that you wish to withdraw your submission. It is only after this is approved that you can re-submit.

BENEFIT:

Winners will be announced on May 27, 2024, and the award ceremony will take place on June 7, 2024.  

APPLY